Thermo Fisher Scientific Inc (NYSE:TMO) Position Boosted by Huntington National Bank

Huntington National Bank raised its position in shares of Thermo Fisher Scientific Inc (NYSE:TMO) by 2.0% during the second quarter, according to its most recent filing with the SEC. The fund owned 190,693 shares of the medical research company’s stock after buying an additional 3,786 shares during the period. Huntington National Bank’s holdings in Thermo Fisher Scientific were worth $33,270,000 at the end of the most recent reporting period.

Other large investors have also added to or reduced their stakes in the company. Independent Portfolio Consultants Inc. boosted its stake in shares of Thermo Fisher Scientific by 0.3% in the first quarter. Independent Portfolio Consultants Inc. now owns 730 shares of the medical research company’s stock valued at $112,000 after buying an additional 2 shares during the last quarter. Sharkey Howes & Javer boosted its stake in shares of Thermo Fisher Scientific by 1.0% in the first quarter. Sharkey Howes & Javer now owns 733 shares of the medical research company’s stock valued at $113,000 after buying an additional 7 shares during the last quarter. Washington Trust Bank boosted its stake in shares of Thermo Fisher Scientific by 0.5% in the first quarter. Washington Trust Bank now owns 2,210 shares of the medical research company’s stock valued at $339,000 after buying an additional 10 shares during the last quarter. Beacon Trust Co. boosted its stake in shares of Thermo Fisher Scientific by 0.6% in the first quarter. Beacon Trust Co. now owns 2,159 shares of the medical research company’s stock valued at $341,000 after buying an additional 12 shares during the last quarter. Finally, Dumont & Blake Investment Advisors LLC boosted its stake in shares of Thermo Fisher Scientific by 0.3% in the first quarter. Dumont & Blake Investment Advisors LLC now owns 5,526 shares of the medical research company’s stock valued at $849,000 after buying an additional 15 shares during the last quarter. 87.15% of the stock is currently owned by institutional investors.

Thermo Fisher Scientific Inc (NYSE:TMO) traded down 0.86% on Thursday, reaching $171.77. 721,372 shares of the company’s stock traded hands. The firm has a market capitalization of $67.01 billion, a PE ratio of 29.93 and a beta of 1.06. The firm’s 50 day moving average price is $176.96 and its 200 day moving average price is $165.20. Thermo Fisher Scientific Inc has a 52-week low of $139.07 and a 52-week high of $182.87.

Thermo Fisher Scientific (NYSE:TMO) last announced its quarterly earnings data on Wednesday, July 26th. The medical research company reported $2.30 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $2.27 by $0.03. Thermo Fisher Scientific had a net margin of 11.80% and a return on equity of 15.97%. The business had revenue of $5 billion for the quarter, compared to analyst estimates of $4.92 billion. During the same period in the prior year, the business posted $2.03 earnings per share. Thermo Fisher Scientific’s revenue was up 10.2% compared to the same quarter last year. On average, analysts predict that Thermo Fisher Scientific Inc will post $9.24 EPS for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, October 16th. Investors of record on Friday, September 15th will be issued a $0.15 dividend. The ex-dividend date of this dividend is Thursday, September 14th. This represents a $0.60 annualized dividend and a yield of 0.35%. Thermo Fisher Scientific’s dividend payout ratio is currently 10.45%.

COPYRIGHT VIOLATION WARNING: “Thermo Fisher Scientific Inc (NYSE:TMO) Position Boosted by Huntington National Bank” was first reported by Ticker Report and is owned by of Ticker Report. If you are accessing this article on another domain, it was stolen and reposted in violation of international copyright & trademark law. The legal version of this article can be accessed at https://www.tickerreport.com/banking-finance/2798910/thermo-fisher-scientific-inc-nysetmo-position-boosted-by-huntington-national-bank.html.

Several brokerages recently commented on TMO. Jefferies Group LLC boosted their target price on Thermo Fisher Scientific from $160.00 to $175.00 and gave the stock a “hold” rating in a report on Friday, April 28th. Deutsche Bank AG set a $200.00 target price on Thermo Fisher Scientific and gave the stock a “buy” rating in a report on Saturday, June 10th. Wells Fargo & Company reissued an “outperform” rating and set a $200.00 target price (up previously from $195.00) on shares of Thermo Fisher Scientific in a report on Thursday, July 13th. Cleveland Research raised Thermo Fisher Scientific from a “neutral” rating to a “buy” rating in a report on Thursday, July 20th. Finally, Bank of America Corporation reissued a “buy” rating and set a $210.00 target price (up previously from $200.00) on shares of Thermo Fisher Scientific in a report on Friday, July 21st. One equities research analyst has rated the stock with a hold rating, sixteen have issued a buy rating and one has issued a strong buy rating to the stock. The stock presently has a consensus rating of “Buy” and a consensus target price of $188.56.

In related news, CFO Stephen Williamson sold 2,500 shares of the stock in a transaction that occurred on Monday, June 5th. The shares were sold at an average price of $176.26, for a total value of $440,650.00. Following the transaction, the chief financial officer now directly owns 37,790 shares in the company, valued at $6,660,865.40. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CEO Marc N. Casper sold 20,000 shares of the stock in a transaction that occurred on Thursday, June 1st. The shares were sold at an average price of $172.79, for a total transaction of $3,455,800.00. Following the completion of the transaction, the chief executive officer now owns 269,279 shares in the company, valued at $46,528,718.41. The disclosure for this sale can be found here. Insiders sold 27,188 shares of company stock worth $4,702,223 over the last 90 days. 0.49% of the stock is currently owned by company insiders.

Thermo Fisher Scientific Company Profile

Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

Want to see what other hedge funds are holding TMO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Thermo Fisher Scientific Inc (NYSE:TMO).

Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Receive News & Ratings for Thermo Fisher Scientific Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific Inc and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

How to Trade on Forex – 8 Steps for Beginners
How to Trade on Forex – 8 Steps for Beginners
Super Nintendo World Theme Park Officially Starts Construction
Super Nintendo World Theme Park Officially Starts Construction
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Camera Zooms In and Can Recognize Faces
Camera Zooms In and Can Recognize Faces
Netflix Could See 150 Million Worldwide Subscribers
Netflix Could See 150 Million Worldwide Subscribers
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back


Leave a Reply

© 2006-2017 Ticker Report. Google+.